BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 11250899)

  • 1. p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2.
    Ito A; Lai CH; Zhao X; Saito S; Hamilton MH; Appella E; Yao TP
    EMBO J; 2001 Mar; 20(6):1331-40. PubMed ID: 11250899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MDMX inhibits the p300/CBP-mediated acetylation of p53.
    Sabbatini P; McCormick F
    DNA Cell Biol; 2002 Jul; 21(7):519-25. PubMed ID: 12162806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of p53 degradation by Mdm2 acetylation.
    Wang X; Taplick J; Geva N; Oren M
    FEBS Lett; 2004 Mar; 561(1-3):195-201. PubMed ID: 15013777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDM2 inhibits p300-mediated p53 acetylation and activation by forming a ternary complex with the two proteins.
    Kobet E; Zeng X; Zhu Y; Keller D; Lu H
    Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12547-52. PubMed ID: 11070080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamics of the p53 acetylation pathway.
    Gu W; Luo J; Brooks CL; Nikolaev AY; Li M
    Novartis Found Symp; 2004; 259():197-205; discussion 205-7, 223-5. PubMed ID: 15171255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 phosphorylation and association with murine double minute 2, c-Jun NH2-terminal kinase, p14ARF, and p300/CBP during the cell cycle and after exposure to ultraviolet irradiation.
    Buschmann T; Adler V; Matusevich E; Fuchs SY; Ronai Z
    Cancer Res; 2000 Feb; 60(4):896-900. PubMed ID: 10706102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation.
    Ito A; Kawaguchi Y; Lai CH; Kovacs JJ; Higashimoto Y; Appella E; Yao TP
    EMBO J; 2002 Nov; 21(22):6236-45. PubMed ID: 12426395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDM2 inhibits PCAF (p300/CREB-binding protein-associated factor)-mediated p53 acetylation.
    Jin Y; Zeng SX; Dai MS; Yang XJ; Lu H
    J Biol Chem; 2002 Aug; 277(34):30838-43. PubMed ID: 12068014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylation regulates the differentiation-specific functions of the retinoblastoma protein.
    Nguyen DX; Baglia LA; Huang SM; Baker CM; McCance DJ
    EMBO J; 2004 Apr; 23(7):1609-18. PubMed ID: 15044952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. YY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stress.
    Grönroos E; Terentiev AA; Punga T; Ericsson J
    Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12165-70. PubMed ID: 15295102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p300/MDM2 complexes participate in MDM2-mediated p53 degradation.
    Grossman SR; Perez M; Kung AL; Joseph M; Mansur C; Xiao ZX; Kumar S; Howley PM; Livingston DM
    Mol Cell; 1998 Oct; 2(4):405-15. PubMed ID: 9809062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E6 oncoprotein represses p53-dependent gene activation via inhibition of protein acetylation independently of inducing p53 degradation.
    Thomas MC; Chiang CM
    Mol Cell; 2005 Jan; 17(2):251-64. PubMed ID: 15664194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human homologue of yeast Rad23 protein A interacts with p300/cyclic AMP-responsive element binding (CREB)-binding protein to down-regulate transcriptional activity of p53.
    Zhu Q; Wani G; Wani MA; Wani AA
    Cancer Res; 2001 Jan; 61(1):64-70. PubMed ID: 11196199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53.
    Honda R; Yasuda H
    EMBO J; 1999 Jan; 18(1):22-7. PubMed ID: 9878046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation.
    Zhou BP; Liao Y; Xia W; Zou Y; Spohn B; Hung MC
    Nat Cell Biol; 2001 Nov; 3(11):973-82. PubMed ID: 11715018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acidic domain is indispensable for MDM2 to negatively regulate the acetylation of p53.
    Wang Q; Yang Y; Wang L; Zhang PZ; Yu L
    Biochem Biophys Res Commun; 2008 Sep; 374(3):437-41. PubMed ID: 18638452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P19(ARF) stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2.
    Tao W; Levine AJ
    Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6937-41. PubMed ID: 10359817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Murine double minute (MDM2) blocks p53-coactivator interaction, a new mechanism for inhibition of p53-dependent gene expression.
    Wadgaonkar R; Collins T
    J Biol Chem; 1999 May; 274(20):13760-7. PubMed ID: 10318779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MDM2 suppresses p73 function without promoting p73 degradation.
    Zeng X; Chen L; Jost CA; Maya R; Keller D; Wang X; Kaelin WG; Oren M; Chen J; Lu H
    Mol Cell Biol; 1999 May; 19(5):3257-66. PubMed ID: 10207051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective p53 post-translational modification required for wild type p53 inactivation in malignant epithelial cells with mdm2 gene amplification.
    Knights CD; Liu Y; Appella E; Kulesz-Martin M
    J Biol Chem; 2003 Dec; 278(52):52890-900. PubMed ID: 14555661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.